Poland wins big in best abstracts prizes at 11th CEM

31 October 2011

Researchers from Poland dominated the EAU 11th Central European Meeting (CEM) held over the weekend in Timisoara, Romania. Innovative studies on prostate and kidney cancers delivered three of the six prizes annually granted by sponsors Richard Wolf and Karl Storz.

“The jury and selection committee had a difficult time selecting the final winners, and we had discussions but finally we had to select the six winners. I am glad to see that through the years we have witnessed a tremendous improvement in quality not only of the research, but also of the presentations and how the participants defended their findings during the final abstract presentations,” said Regional Office Chairman Prof. Michael Marberger.

Presenting the awards together with Prof. Viorel Bucuras, chairman of the local organising committee, both Marberger and Bucuras noted the high quality of abstract submissions this year. Host country Romania and Poland were also the top abstract submitters this year accounting for 52 and 51 abstracts, respectively, out of the 176 accepted abstracts. Czech Republic came third with 22 accepted abstracts.

First prize winner for Karl Storz were J. Wilkosz and colleagues from Poland for their study on differential expression of O-GlcNAc transferase in prostate neoplasms, while T. Urge and colleagues from the Czech Republic bagged the Richard Wolf first prize for their study on oncocytic papillary renal cell carcinoma in clinical praxis.

Below is a list of the six winners and the respective titles of the winning studies:

Karl Storz:

First Prize, J. Wilkosz, et al., Differential expression of O-GlcNAc transferase and O-GlcNacase genese in prostate neoplasms, Medical University of Od Lodz, Lodz, Poland

Second Prize, C. Gingu, et al., Primary carcinoma of the male urethra- diagnosis and treatment; Fundeni Clinical Institute, Bucharest, Romania

Third Prize: B. Sudarevic, et al., Lack of association of interleukin-10 polymorphism and prostate cancer risk in Eastern Croatian population, Clinical Hospital Centre Osijek, Croatia

Richard Wolf:

First Prize: T. Urge, et al., Oncocytic papillary renal cell carcinoma in clinical praxis, University Hospital Plzen, Czech Republic

Second Prize: W.A. Cieslikowski, et al., Co-administration of tyrosine kinase inhibitors with Rottlerin in metastatic prostate cancer,  University of Medical Sciences, Poznan, Poland

Third Prize: A. Kaluzny, et al., et al., Shokeir ileoplasty for urethral reconstruction; Medical University of Gdansk, Poland